Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Shivdeep Dhaliwal

Novavax Scores Approval From Australian Regulator For COVID-19 Vaccine

Novavax Inc (NASDAQ:NVAX) said Wednesday that Australia’s national drugs regulator has granted approval for its COVID-19 vaccine.

What Happened: The Maryland-based biotechnology company said that Australia’s Therapeutic Goods Administration or TGA granted approval for provisional registration of its NVX-CoV2373 vaccine for prevention of COVID-19 in individuals 18 years of age and older.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.